Biofrontera Inc. Announces Notice of Allowance for U.S. Patent on Innovative Illumination Protocol
02 déc. 2021 09h15 HE
|
Biofrontera Inc.
WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that...